Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference73 articles.
1. Master protocols: efficient clinical trial design strategies to expedite development of oncology drugs and biologics. Guidance for Industry. U.S. Department of Health and Human Services. Food and Drug Administration; 2018.
2. Liu F, Li N, Li W, Chen C. Impact of clinical center variation on efficiency of exploratory umbrella design. Stat Biosci 2019:1–20.
3. NCI-COG Pediatric MATCH. https://www.cancer.gov/about-cancer/treatment/clinical-trials/nci-supported/pediatric-match. 2020.
4. Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT. Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380:1103–15.
5. Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma. N Engl J Med. 2019;380:1116–27.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献